C
CTX
vs
W
WIG20
Over the past 12 months, CTX has outperformed WIG20, delivering a return of +52% compared to the WIG20's +33% growth.
Stocks Performance
CTX vs WIG20
Performance Gap
CTX vs WIG20
Performance By Year
CTX vs WIG20
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Captor Therapeutics SA
Glance View
Captor Therapeutics SA engages in the development of protein degradation drugs for cancer and autoimmune diseases. The company is headquartered in Wroclaw, Woj. Dolnoslaskie and currently employs 98 full-time employees. The company went IPO on 2021-04-19. The firm works in the field of neoplastic and autoimmune diseases for which there is no treatment option, or the available methods show therapeutic limitations. The firm covers aspects of early-stage drug development to deliver therapeutics for life-threatening and life-impairing diseases. The broadly applicable Optigrade tm Targeted Protein Degradation (TPD) platform allows for the creation of new drugs.